Another stock I really like VNDA

Shea · Jun 23, 2008

Got in this stock a few weeks ago and added today on the dip to $5.80. This stock was trading at $23.00 a year ago and is closer today on approval of one of its lead drugs which goes for FDA approval later July. In addition, they have another drug in late stage 3 testing to treat sleep disorders. good news just around the corner? I think so IMHO.

Shea · Jun 24, 2008

OUCH! This stock tanked yesterday, currently trading at $5.00 bucks! Made a nice run last week to be giving back in one day. If I goes to $4.80 today I'll be adding more. Alot of buying last week at levels much higher.
This of course is only an opinion but any drug that treats insominia could be big. Big on the news that it may work, much bigger if it actually does.

dauis · Jun 24, 2008

I also really like this stock. It's the biggest position in my portfolio. While the insomnia drug is nice, the big price mover will be the schizophrenia drug, Fanapta. Only a few more weeks until we have approval news.

dauis · Jun 26, 2008

Positive Phase III data for the insomnia drug:

http://biz.yahoo.com/prnews/080626/neth035.html?.v=58

Some good news that should tide everyone over until the Fanapta decision.

Shea · Jun 26, 2008

News just broke. "Tasimelteon significantly improves sleep in patients with chronic insominia in phase III study". Although this if far from an FDA approval the stock should do well in the next 30 days. Also, as mentioned the Schizophrenia drug go to FDA for approval late July! Good things to follow IMHO.

Shea · Jun 30, 2008

Well this stock is now trading in the mid three's. Not sure as to why the walk down but nothing surprises me anymore. I believe everyone was expecting a more favorable PR last week on the insominia drug. Anyway, the schizophrenia drug goes up for approval in four short weeks. I would add more at this level but I already own as many as I'm will to gamble here.

PercocetThreat · Jun 30, 2008

Small cap drug/bio's are tough. If you still have faith then hang in there, you just have to be able to stomach the volatility. It ain't easy, I know.

PercocetThreat · Jul 30, 2008

Tough break on VNDA; looks attractive with cash per share of around $2.50 but they are going to burn through that in about 18 months. Looks like partnership or death.

Shea · Aug 1, 2008

Yep...sitting on 1200 shares at an average cost of about $4.60. I need a partnership to save my ass.

Shea · Aug 13, 2008

CEO and other insiders have purchased a number of shares in the past few days. Some say the cash value alone is worth $2.50 per share. At the current trade of around $1.20 per share perhaps there is some value here? Too risky or worth a shot?

PercocetThreat · Aug 14, 2008

That $2.50/sh is a smoke screen. They are going to burn through that in 18 months max and it's doubtful that any of their drugs in development is hitting the market in under 2 years.

In my opinion it's a total loser but if you think they got something then stick it out.

Good luck.